SCHEMBL4863695

SCHEMBL4863695

CC[C@@H]1C(=O)N(C(C)C)c2ccc(F)cc2N1C(=O)c1ccc(OC)cc1

nearest known ligand 0.43

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.41
NPC1 O15118 1/20 0.41
GAA P10253 1/20 0.41
RAB9A P51151 1/20 0.41
ALDH1A1 P00352 3/20 0.40
TSHR P16473 3/20 0.40
LMNA P02545 2/20 0.40
HTT P42858 1/20 0.40
TP53 P04637 3/20 0.39
HSD11B1 P28845 1/20 0.38
P2RY1 P47900 2/20 0.36
POLB P06746 1/20 0.36
NQO2 P16083 1/20 0.36
PTGER2 P43116 1/20 0.36
PDE3B Q13370 1/20 0.36
PDE3A Q14432 1/20 0.36
LTB4R Q15722 1/20 0.36
PTGDR2 Q9Y5Y4 1/20 0.36
PKM P14618 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4864131 0.89 KMT2A (0.36)
SCHEMBL4866466 0.86 SMN1; SMN2 (0.43) SMN1; SMN2NPC1GAARAB9AALDH1A1
SCHEMBL4867889 0.86 SMN1; SMN2 (0.43) SMN1; SMN2NPC1GAARAB9AALDH1A1
SCHEMBL4870214 0.86 SMN1; SMN2 (0.39) SMN1; SMN2NPC1GAARAB9AALDH1A1
SCHEMBL4867553 0.85 USP2 (0.45) SMN1; SMN2NPC1GAARAB9AALDH1A1
SCHEMBL4864075 0.85 USP2 (0.45) SMN1; SMN2NPC1GAARAB9AALDH1A1
SCHEMBL4870374 0.84 SMN1; SMN2 (0.43) SMN1; SMN2NPC1GAARAB9AALDH1A1
SCHEMBL4867565 0.84 ALDH1A1 (0.47) SMN1; SMN2NPC1GAARAB9AALDH1A1
SCHEMBL4870059 0.83 USP2 (0.45) SMN1; SMN2NPC1GAARAB9AALDH1A1
SCHEMBL4864292 0.82 ALDH1A1 (0.41) SMN1; SMN2NPC1GAARAB9AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7351709-B2 Estrogen receptor ligands WYETH (US) 2008-04-01 US disclosed
US-20060019961-A1 Estrogen receptor ligands WYETH 2006-01-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060019961-A1 Estrogen receptor ligands GPER1, ESR2, ESR1 SMN1; SMN2 4822/4885NPC1 1178/4885GAA 2671/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.